Rasmus Stenlid
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.
Journal: Cardiovascular diabetology
Published: November 02, 2025
The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.
Journal: Obesity facts
Published: October 29, 2025
Asthma diagnosis is not associated with reduced beta-cell function in children and adolescents with obesity.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: June 27, 2025
Evaluation of BMI Growth Charts for Children Living with Severe Obesity.
Journal: Childhood obesity (Print)
Published: June 26, 2025
Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.
Journal: Cardiovascular diabetology
Published: April 14, 2025
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.
Journal: Frontiers in endocrinology
Published: September 12, 2023
Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate-exposed human islets.
Journal: Diabetes, obesity & metabolism
Published: June 13, 2023
Last Updated: 09/26/2026